Gold Is Being Reintroduced Into the Monetary System

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

FedEx Bets On Cost Cuts To Boost Margins, Says Analyst

Nabaparna Bhattacharya
September 19, 2025

FedEx Corporation (NYSE:FDX) shares surged as the company reported a strong quarterly performance, surpassing revenue and profit expectations.

The company reported adjusted earnings per share of $3.83, beating the consensus estimate of $3.62. In addition, FedEx reported sales of $22.20 billion, beating the consensus estimate of $21.66 billion.

Bank of America analyst Ken Hoexter reiterated the Neutral rating on the stock, raising the price forecast from $240 to $244.

Also Read: These Analysts Revise Their Forecasts On FedEx After Q1 Results

Hoexter said FedEx has historically traded at 12.5x–18.5x earnings, but its current multiple is pressured by macro sensitivity and ongoing volume declines.

He noted that cost reductions should support margins as earnings inflect, while management stays focused on integrating Ground and Express, removing structural costs, and improving returns.

He added that FedEx benefits from cross-border trade growth and generally tracks the broader economy.

The analyst highlighted that FedEx's fiscal 2026 adjusted EPS target of $17.20–$19.00 implies a slight year-over-year decline on 4%–6% revenue growth.

He added that guidance includes a $1 billion operating-income drag from global-trade shifts, including the loss of de minimis, shifting volumes, and $300 million in customs-clearance costs, and a $160 million hit from the USPS contract ending in September, partly offset by $1 billion in transformation savings.

The analyst added that mix pressure persists as weaker Express International is balanced by Domestic share gains, including Amazon (NASDAQ:AMZN) ramps that are profitable but lower-margin.

The analyst raised the fiscal 2026 earnings estimates from $17.75 to $18.00. Hoexter raised the fiscal 2027 earnings estimate from $20.45 to $21.05.

Price Action: FDX shares were trading higher by 2.95% to $233.26 at last check Friday.

Read Next:

  • How To Earn $500 A Month From PepsiCo Stock

Photo via Shutterstock

Continue Reading...

Popular

FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite

FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.

Power, politics and performance: Russia's revamped Intervision song contest names a winner

When Vietnamese singer Duc Phuc held aloft the crystal cup trophy in Moscow’s Live Arena on Saturday night, he became the inaugural winner of — a Russian answer to Eurovision that some say is as much about politics and power as it is about performance.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Trump files $15 billion defamation lawsuit against The New York Times

NEW YORK (AP) — President Donald Trump filed a $15 billion defamation lawsuit against The New York Times and four of its journalists on Monday, according to court documents.

China accuses Nvidia of violating antimonopoly laws following preliminary investigation

LONDON (AP) — China accused Nvidia on Monday of violating the country’s antimonopoly laws and said it would step up scrutiny of the world’s leading chipmaker, escalating tensions with Washington as the two countries hold trade talks this week.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

SoFi Bets Big On AI With First ETF Launch In Two Years

SoFi re-enters the ETF market with its Agentic AI fund, targeting next-gen AI leaders from Nvidia to Deere amid a crowded thematic investing space.

Enanta's RSV Pill Shows Promise In Cutting Recovery Time For High-Risk Adults

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are at high risk of complications, including the elderly and/or those with congestive heart failure (CHF), chro

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

US To Impose $100,000 Annual Fee On H-1B Visas As Analysts Warn Trump Risks 'Taxing Away' America's Innovation Edge

The Trump administration's plan to impose a $100,000 annual fee on H-1B visas could reshape tech hiring, strain talent pipelines from India and China, and risk driving innovation overseas, analysts warn.

Tesla Faces Class Action Over 'Wage Theft' Amid Preference For H-1B Workers Following Elon Musk's Push To Optimize Visa Practice

Tesla is facing a federal class action lawsuit accusing it of favoring H-1B visa holders over U.S. workers to cut labor costs, even as the company battles financial headwinds and regulatory scrutiny.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Opendoor Is A 'Stock That Could Be The Amazon Of Housing': Eric Jackson

Eric Jackson sees Opendoor as able to simplify the experience of buying and selling a home in the same way that Amazon revolutionized retail.

How Malawi is taking AI technology to small-scale farmers who don't have smartphones

MULANJE, Malawi (AP) — Alex Maere survived the destruction of when it tore through southern Malawi in 2023. His farm didn't.

Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad

If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."

Scott Bessent Meets BlackRock's Rick Rieder As Trump Eyes Fed Chair Replacement For Jerome Powell: Report

Scott Bessent is interviewing candidates to replace Jerome Powell as Federal Reserve Chair by May 2026, with BlackRock's Rick Rieder among those being considered.

New England's shrimp industry is struggling, with fishermen catching few in 2025

PORTLAND, Maine (AP) — There's an effort underway to bring New England shrimp back to seafood customers — but fishermen have found few of the crustaceans, and the fishing industry that harvests them may face an even longer shutdown.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

A United Airlines passenger plane makes emergency landing in Osaka as cargo fire is suspected

NAGASAKI, Japan (AP) — A United Airlines passenger plane carrying 142 people and bound for the Philippine island of Cebu made an emergency landing in Osaka on Friday after an indicator showed a fire in the cargo room, Japanese aviation officials said.

Workday Stock Jumps After Activist Investor Reveals $2 Billion Stake

Shares of Workday Inc. (NASDAQ:WDAY) are rising Wednesday after activist investor Elliott Investment Management revealed a $2 billion stake in the human resources technology firm, signaling strong confidence in recent moves.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Crypto Is The Money For AI, Says Economist As Coinbase CEO Teases Stablecoin-Powered Transactions Between Agents

Renowned economist Alex Tabbarok described cryptocurrencies as the “money” for artificial intelligence on Tuesday after Coinbase Global Inc. (NASDAQ:COIN) CEO teased a new feature that enables AI agents to transact using stablecoins.

Charlie Kirk Raised $85 Million Last Year — Widow Vows to Continue His Work

The assassination of Turning Point USA founder Charlie Kirk at a Utah Valley University event on September 10 has cast a shadow of uncertainty over the future of his political and business ventures.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Day of strikes in France challenges new prime minister's budget plans

PARIS (AP) — Strikes and street demonstrations called by all major trade unions to denounce budget cuts were expected Thursday across France, as new talks with political opponents about curbing .

Georgia judge won't award attorneys fees to governments in lawsuit over Rivian vehicle plant

ATLANTA (AP) — A judge has rejected an attempt by the state of Georgia and a local development agency to force people who unsuccessfully sued to block an electric vehicle plant to pay the government's legal fees.

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

Ben & Jerry's Co-Founder Resigns In Protest As Politics Continue To Influence Corporate Exits

Jerry Greenfield, of Ben & Jerry's fame, didn't resign over personal controversy—he quit because his company stopped being political enough.

What to know after US says it has reached framework deal with China to keep TikTok in operation

TikTok users in the U.S. may get a reprieve from the threat of a shutdown after the Trump administration announced it has reached a framework deal with China for the ownership of the popular .

Gold Is Being Reintroduced Into the Monetary System - Ad

While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.

Google's top AI scientist says ‘learning how to learn’ will be next generation's most needed skill

ATHENS, Greece (AP) — A top Google scientist and 2024 Nobel laureate said Friday that the most important skill for the next generation will be “learning how to learn” to keep pace with change as transforms education and the workplace.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO

The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).

US Farmers Head To China As Trade Strains Weigh: Report

U.S. farmers plan a November mission to China, seeking to revive agricultural trade as tensions strain commodity flows.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Appeals court rejects Trump's bid to unseat Federal Reserve governor Lisa Cook ahead of rate vote

WASHINGTON (AP) — An appeals court ruled Monday that can remain a Federal Reserve governor, rebuffing President Donald Trump’s efforts to remove her just ahead of a key vote on interest rates.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright priceactionea.net
Privacy Policy | Terms of Service